Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
- PMID: 34510832
- PMCID: PMC8435272
- DOI: 10.1002/hep4.1733
Hepatocellular Carcinoma Risk, Outcomes, and Screening After Hepatitis C Eradication
References
-
- Waziry R, Hajarizadeh B, Grebely J, Amin J, Law M, Danta M, et al. Hepatocellular carcinoma risk following direct‐acting antiviral HCV therapy: a systematic review, meta‐analysis, and meta‐regression. J Hepatol 2017;67:1204‐1212. - PubMed
-
- Conti F, Buonfiglioli F, Scuteri A, Crespi C, Bolondi L, Caraceni P, et al. Early occurrence and recurrence of hepatocellular carcinoma in HCV‐related cirrhosis treated with direct‐acting antivirals. J Hepatol 2016;65:727‐733. - PubMed
-
- Reig M, Marino Z, Perrello C, Inarrairaegui M, Ribeiro A, Lens S, et al. Unexpected high rate of early tumour recurrence in patients with HCV‐related HCC undergoing interferon‐free therapy. J Hepatol 2016;65:719‐726. - PubMed
Publication types
LinkOut - more resources
Full Text Sources